FOXA1 IS A MEMBER of the winged helix family of transcription factors and shares structural similarities with Foxa2 and Foxa3 (previously termed HNF3␣, HNF3␤, and HNF3␥, respectively). Foxa genes are widely expressed during embryonic development in vertebrates. During formation of the definitive endoderm, Foxa2 is expressed before Foxa1 and Foxa3 (2, 29, 36) . In the early embryo, Foxa2 is expressed in the node, notochord, and floor plate, whereas Foxa1 is detected only in the notochord and floor plate (2, 29, 34, 36) . Later in embryonic development and adulthood, Foxa1 and Foxa2 are detected in tissues of endodermal, ectodermal, and mesodermal origins (3, 18, 21) .
In the lung, Foxa1 and Foxa2 are first expressed at the onset of lung bud formation and are present in the adult lung, where they are coexpressed in epithelial cells of conducting airways and in type II epithelial cells in the alveoli (3) . Foxa2 is strictly required during the alveolar period of lung morphogenesis as revealed by tissue-specific gene ablation (41, 42) . Foxa2 plays an important role during alveolarization and regulates epithelial cell differentiation after birth. When Foxa2 is deleted in epithelial cells of the developing lung (Foxa2 ⌬/⌬ mice), abnormalities in alveolarization are observed at PN3 that are associated with decreased alveolar septation and fewer peripheral lung saccules. At postnatal day (PN) 16 and thereafter, Foxa2 ⌬/⌬ mice develop emphysema and goblet cell hyperplasia in the bronchi and bronchioles (41) . Newborn mice lacking Foxa2 in the lung develop severe pulmonary disease on the first day of life with the features of respiratory distress syndrome. Thus Foxa2 plays a critical role during the transition to air breathing at birth (42) . Foxa2 regulates the transcription of several genes that play important roles in lung morphogenesis and homeostasis, including Titf1 (15) , Sftpb (6) , and Scgblal (4, 5) . Although the sites of expression of Foxa1 and Foxa2 overlap in the developing and mature lung (3), the role of Foxa1 in lung development and function has not been established.
Targeted disruption of Foxa1 in mice is characterized by reduced survival after birth due to severe hypoglycemia and dehydration (19, 39) and is associated with abnormally low glucagon levels. No changes were observed in expression of genes associated with glucose metabolism or in transcription factors that might compensate for the lack of Foxa1 in the liver (19) . Despite growth retardation, no apparent morphological abnormalities were observed in tissues expressing Foxa1, including the gastrointestinal tract, liver, and pancreas. In this study, we assessed the role of Foxa1 during lung development. We demonstrate that Foxa1 regulated maturation of respiratory epithelial cells during the pre-and postnatal period.
MATERIALS AND METHODS

Animal husbandry. Foxa1
ϩ/Ϫ mice (129SvEv ϫ C57BL/6) were derived at the University of Pennsylvania, as previously described (19) , and were maintained as heterozygotes. Transgenic mice were identified by PCR with genomic DNA from the tails of fetal and postnatal mice, as previously described (32) . Animals were housed in pathogen-free conditions according to protocols approved by Institutional Animal Care and Use Committee at Cincinnati Children's Hospital Research Foundation. All animals were housed in humidityand temperature-controlled rooms on a 12:12-h light-dark cycle and were allowed food and water ad libitum. There was no serological evidence of either pulmonary or systemic pathogens in sentinel mice maintained within the colony. No serological evidence of viral infection or histological evidence of bacterial infection was detected in representative mice.
Tissue preparation and immunohistochemistry. The body and lung weight data were collected at the time of death. For embryonic data, gestational age was determined by detection of the vaginal plug [as embryonic day (E) 0.5] and correlated with the length and weight of each pup at the time of death. Whole embryos were weighed after being removed from the yolk sac, washed, and dried. For the postnatal study, the mice were first weighed and then killed by an injection of 0.25 ml of anesthetic (ketamine, xylazine, acepromazine) and exsanguinated. In both cases, wet lung weights were measured after the heart, trachea, and bronchi have been removed. Embryonic lungs were immersed in 4% paraformaldehyde in PBS (20 mM Tris ⅐ HCl, pH 7.6, 137 mM NaCl), whereas postnatal lungs were inflation fixed with the same fixative at 25 cmH 2O before immersion. Lungs were fixed overnight, washed with PBS, dehydrated in a series of alcohols, and embedded in paraffin. Immunohistochemistry was performed on tissue sections by a microwave antigen-retrieval technique for the transcription factors (38) . Sections were pretreated with 3% H 2O2 in methanol for inactivation of endogenous peroxidase and then blocked in 4% normal goat serum for 2 h before incubation with the primary antibody overnight at 4°C. Antibodies used were generated to: prosurfactant protein (SP)-C (1:1,000, rabbit polyclonal, AB3428, Chemicon), Clara cell secretory protein (CCSP, 1:7,500, rabbit polyclonal; kindly provided by Dr Barry Stripp, University of Pittsburgh), SP-B (1:1,000 to 1:2,000, rabbit polyclonal, Chemicon, Temecula, CA), thyroid transcription factor (TTF-1, 1:1,000, rabbit polyclonal, generated in this laboratory), Foxa2 [1:8,000, rabbit polyclonal, (3)], Foxj1 [1:8,000, rabbit polyclonal (40)], and ␤-tubulin (1:800, mouse monoclonal; ONS1A6, BioGenex). After being rinsed, tissue sections were incubated with biotinylated goat anti-guinea pig IgG or goat anti-rabbit IgG (7.5 g/ml; Vector Laboratories, Burlingame, CA) for 30 min and detected with an avidin-biotin peroxidase complex detection kit (Vectastain Elite ABC kit; Vector Laboratories, Burlingame, CA) using nickel-diaminobenzidine as a substrate. The precipitation reaction was enhanced with Tris-cobalt, and the sections were counterstained with 0.1% of nuclear fast red. All experiments shown are representative of findings from at least four independent dams, each generating at least one or two Foxa1 Ϫ/Ϫ mice that were compared with Foxa1 ϩ/ϩ littermates. For ultrastructural analysis, lung tissue from E17.5 and E18.5 Foxa1 Ϫ/Ϫ mice and littermate controls (matched for body weight) was fixed in modified Karnovsky's fixative, consisting of 2% glutaraldehyde and 2% paraformaldehyde in 0.1 M sodium cacodylate buffer (SCB) plus 0.1% calcium chloride (pH 7.3). The tissue was postfixed in 1% osmium tetroxide in 0.1 M SCB, dehydrated, and embedded in epoxy resin (EMbed 812; Electron Microscopy Sciences, Fort Washington, PA), as previously described (46) . Ultrathin sections were viewed in a Hitachi H-7600 transmission electron microscope, and digitized images were collected with an AMT Advantage Plus 2K ϫ 2K digital camera (Advanced Microscopy Techniques, Danvers, MA).
Morphometry. Morphometric measurements were performed on mice at PN5 and PN13. Three to five mice of both genotypes were studied at each age. The overall proportion (% fractional area) of respiratory parenchyma and air space was determined by a pointcounting method (7, 43) . Measurements were performed on two sections taken at intervals throughout the left, right upper, or right lower lobes. Slides were viewed by through a ϫ20 objective, and the images (fields) were transferred by video camera to a computer screen using Metamorph imaging software (Universal Imaging, West Chester, PA). A computer-generated, 121-point lattice grid was superimposed on each field, and the number of intersections (points) falling over respiratory parenchyma (alveoli and alveolar ducts) or air space was counted. Points falling over bronchioles, large vessels, and smaller arterioles and venules were excluded from the study. Fractional areas (% Fx area) were calculated by dividing the number of points for each compartment (n) by the total number of points contained within the field (N), and then multiplying by 100: % Fx area ϭ n/N ϫ 100. Fifteen fields per section were analyzed to gather the data. The x-and y-coordinates for each field measured were selected by a random number generator. Likewise, counting of secondary septa was performed on five fields per section of three to five mice of both genotypes and results were normalized per lung area.
RNA analysis. S1 nuclease protection and RNase protection assays were performed as described previously (16, 33) . mRNAs encoding SP-A, SP-B, SP-C, SP-D, CCSP, TTF-1, and Foxa2 were quantified by either S1 nuclease protection assay or RNase protection assay with ribosomal protein L32 as an internal control. A rat Foxa2 probe was kindly provided by Dr. R. Costa of the University of Illinois. Figures are representative of at least four individual mice at each time for each group.
Cell culture and transfection assays. Mouse lung epithelial cells, MLE-15, an immortalized mouse lung epithelial cell line that maintains some morphological and functional characteristics of type II epithelial cells, were cultured in HITES medium (45) . Lung adenocarcinoma cells NCI-H441 (ATCC HTB 174) and cervical cancer cells HeLa (ATCC CCl-2) were obtained from the American Type Culture Collection (ATCC, Rockville, MD). HeLa cells were grown in Dulbecco's modified Eagle's medium, and H441 cells were grown in RPMI containing 4.5g/l D-glucose and 10 mM HEPES, both media supplemented with 50 units of penicillin/ml, 50 g of streptomycin/ ml, and 10% fetal calf serum. Cells were transfected with the Effectene transfection reagent (Qiagen) according to the manufacturer's protocol. The reporter constructs were: 1.1 kb mouse SP-A-luc, 0.5 kb human SP-B-luc, 1.8 kb mouse SP-B-luc, 4.8 kb mouse SP-C-luc, 0.7 kb mouse SP-D-luc (12), 2.3 kb rCCSP-luc, or 3.7 kb mouse MUC5AC-luc (kindly provided by Dr. Carol Basbaum, University of San Francisco) (22) and were cotransfected with either empty vector pcDNA3.1 or pcDNA3.1 containing the full-length mouse Foxa1 cDNA. Forty-eight hours after transfection, luciferase activity was assessed and normalized for cotransfection efficiency by ␤-galactosidase activity. All transfections were performed in triplicate. pcDNA3.1 (Invitrogen) and pCMV ␤-galactosidase (Clontech) vectors were used to normalize DNA and transfection efficiency, respectively.
Statistical analysis. ANOVA and Student's t-test were used to determine differences between groups. In the morphometric study, statistical differences were determined by the 2 -test for fractional areas and unpaired Student's t-test for comparison of septa formation. Values for all measurements were expressed as means Ϯ SE, and P values for significance were Ͻ0.05.
RESULTS
Lung morphogenesis is temporarily delayed in Foxa1-deficient mice.
To assess the role of Foxa1 in lung development, we used Foxa1 Ϫ/Ϫ gene-targeted mice (19) . Embryos obtained before birth showed no apparent morphological abnormalities. As reported previously, most of the Foxa1 Ϫ/Ϫ mice died within the first week of life. The longest survivors died at PN13. Body weights in Foxa1 Ϫ/Ϫ and Foxa1 ϩ/ϩ control littermates were not altered before birth (Fig. 1A) . However, at PN5, the Foxa1 Ϫ/Ϫ mice had a lower body weight compared with littermates. In contrast, the Foxa1 ϩ/ϩ and Foxa1 ϩ/Ϫ mice gained weight normally. The lung-to-body weight (LW/BW) ratios were similar in each genotype at all time points examined, indicating that lung growth was not selectively altered in Foxa1 Ϫ/Ϫ mice (Fig. 1C ) but corresponded to general body growth.
Next we investigated perinatal lung development in embryos at E16.5, E17.5, and E18.5 and pups at PN5 and PN13. At E16.5, morphological maturation of the lungs was delayed in Foxa1 Ϫ/Ϫ mice compared with control littermates (Fig. 2, A  and B ). Whereas lung maturation had reached the saccular stage of lung development, with dilatation of the distal lung saccules occurring in Foxa1 ϩ/ϩ mice, lung morphology in the Foxa1 Ϫ/Ϫ mice remained in the canalicular stage. However, by E17.5 and E18.5, lungs from Foxa1 Ϫ/Ϫ and Foxa1 ϩ/ϩ mice were similar with no obvious structural differences in saccule formation (Fig. 2, C-F) . After birth, differences between the lungs of Foxa1 Ϫ/Ϫ mice and control littermates were readily apparent (Fig. 2, G and H) . At PN5, lungs from Foxa1 Ϫ/Ϫ mice had thinner inter-air space septa, larger and fewer air spaces, and a reduction in the number of secondary septa compared with the Foxa1 ϩ/ϩ mice. By PN13, septation had progressed to normal in the surviving Foxa1 Ϫ/Ϫ mice (Fig. 2, I and J). Morphometric analysis showed significant statistical differences in the relative proportion of air space (Fig. 3A) and respiratory parenchyma (Fig. 3B) at PN5 in the Foxa1 Ϫ/Ϫ mice compared with the Foxa1 ϩ/ϩ mice. The percentage of fractional area of air space was increased significantly (P Ͻ 0.001) in Foxa1 Ϫ/Ϫ mice, whereas no statistical difference was observed at PN13 between the two groups. Likewise, respiratory parenchyma was decreased at PN5 in the Foxa1 Ϫ/Ϫ mice compared with the Foxa1 ϩ/ϩ mice, whereas no statistical difference was noticed at PN13. Study of alveolar septation shows that secondary septa formation is dramatically reduced in the Foxa1 Ϫ/Ϫ mice compared with the Foxa1 ϩ/ϩ mice at PN5. The morphometric results were consistent with the histological findings.
At the ultrastructural level, at E17.5, ciliated and nonciliated columnar epithelial cells were present in conducting airways of Foxa1 Ϫ/Ϫ and Foxa1 ϩ/ϩ mice. Cuboidal type II cells were observed throughout the peripheral lung epithelium in both genotypes. Type II cells in the Foxa1 Ϫ/Ϫ mice had more glycogen, fewer lamellar bodies, and less secreted surfactant (Fig. 4) . Squamous type I cells were infrequent in the Foxa1 Ϫ/Ϫ mice. At E18.5, no differences were observed at the ultrastructural level in the conducting airways or peripheral epithelium between the Foxa1 Ϫ/Ϫ and Foxa1 ϩ/ϩ mice (data not shown).
Effects of Foxa1 deletion on epithelial cell gene expression.
To evaluate the differentiation of respiratory epithelial cells in Foxa1 Ϫ/Ϫ mice, we performed immunohistochemistry for differentiation-dependent markers that were specific for conducting or peripheral airways from E16.5 to PN13. CCSP, a marker for nonciliated bronchiolar cells, was absent in the conducting airways of Foxa1 Ϫ/Ϫ mice at E16.5 and E17.5 and was readily detected, albeit at relatively reduced levels, at E18.5. In Foxa1 ϩ/ϩ mice, CCSP was detected at E16.5 (Fig. 5) . However, after birth, no differences in CCSP staining were observed in Foxa1 Ϫ/Ϫ and Foxa1 ϩ/ϩ mice. Expression of proand mature SP-B, a surfactant protein expressed by both type II and bronchiolar cells, was decreased in the Foxa1 Ϫ/Ϫ mice at E16.5, E17.5, and E18.5 (Fig. 6, A-F) . After birth, intensity of SP-B staining was decreased in the Foxa1 Ϫ/Ϫ mice at PN5, whereas no differences were observed at PN13 (Fig. 6, G-J) . Likewise, intensity of staining for pro-SP-C, a selective marker for type II cells, was decreased in the Foxa1 Ϫ/Ϫ mice at E16.5-E18.5 (Fig. 7, A-F) . Again after birth, staining for pro-SP-C was similar the Foxa1 Ϫ/Ϫ mice and control littermates (Fig. 7, G-I ). T1␣ (a type I cell marker), Foxj1, and ␤-tubulin (ciliated cell markers) were also unaltered after birth. Consistent with these observations, immunoblotting studies demonstrated that the abundance of SP-B and CCSP was decreased at E18.8 and PN5 in Foxa1 Ϫ/Ϫ mice (data not shown). In contrast, the abundance of SP-A and SP-D in lung homogenates was not altered in Foxa1 Ϫ/Ϫ mice compared with wild-type controls at any of the time points.
To determine whether the changes in SP-B, SP-C, and CCSP immunostaining were associated with changes in their respective mRNAs, we performed S1 nuclease assays on lung RNA samples from Foxa1 Ϫ/Ϫ and Foxa1 ϩ/ϩ mice at E16.5, E17.5, E18.5, and PN5 (Fig. 8) . SP-A mRNA levels were decreased in Foxa1 Ϫ/Ϫ mice at PN5 (Fig. 8A) . At E16.5, SP-B and SP-C mRNAs were significantly reduced in the Foxa1 Ϫ/Ϫ mice compared with the control littermates. In contrast, at E17.5 and later, no differences in SP-B, SP-C, and SP-D mRNAs were observed in the Foxa1 Ϫ/Ϫ mice (Fig. 8D) . Consistent with 8E) . CCSP mRNA was decreased by 50% at E17.5 and E18.5. After birth, CCSP mRNA was similar in Foxa1 Ϫ/Ϫ and Foxa1 ϩ/ϩ mice. Thus maturation of both lung morphology and expression of epithelial differentiation were delayed in late gestation in Foxa1 Ϫ/Ϫ mice.
Foxa1 regulates lung epithelial cell gene expression in vitro.
To assess whether Foxa1 directly regulated lung epithelial cell gene expression, we cotransfected luciferase reporter constructs driven by SP-A, SP-B, SP-C, SP-D, and CCSP promoters with increasing concentrations of a Foxa1 expression vector into HeLa, H441, or MLE-15 cells. Foxa1 significantly increased the activity of the SP-A, SP-D, and CCSP-luciferase constructs in a dose-dependent manner (Fig. 9, A, E, and F) . In contrast, Foxa1 inhibited the murine SP-C promoter construct (Fig. 9D ). Foxa1 inhibited both human and mouse SP-B promoter activity in H441 and MLE-15 cells (Fig. 9, B and C) . Foxa1 did not alter activity of the MUC5AC-luciferase construct (data not shown). Thus Foxa1 activates a number of lung epithelium-specific genes including SP-A, SP-D, and CCSP in vitro. While Foxa1 and Foxa2 bind to the same DNA binding motifs, transcriptional effects of Foxa1 are both similar (42) and distinct (13, 37, 41 ) from Foxa2 on various target genes. The discrepancies between in vitro and in vivo effects of Foxa1 on various target genes suggests that Foxa1 likely to have both direct and indirect effects on gene transcription in the developing lung. Alternatively, compensatory mechanisms may further influence gene expression at various times in development.
Transcription factors expression in Foxa1 Ϫ/Ϫ mice. To determine whether other transcription factors could compensate for the lack of Foxa1 in the regulation of lung epithelial cell genes, we assessed the expression of Foxa2 and TTF-1, markers for both proximal and distal airways, by immunohistochemistry. Sites and intensity of Foxa2 and TTF-1 staining were similar in both Foxa1 Ϫ/Ϫ and Foxa1 ϩ/ϩ mice in bronchiolar and alveolar epithelial cells at all development stages examined ( Fig. 10 and data not shown). Consistent with these observations, no differences in Foxa2 or TTF-1 mRNA levels were observed in Foxa1 Ϫ/Ϫ mice at various time points (Fig. 11) .
DISCUSSION
Although Foxa1 is not required for respiration at birth, deletion of Foxa1 influences lung morphogenesis and epithelial cell differentiation at distinct times during perinatal development. Because delayed lung maturation may impair respiratory function during the transition to air breathing in neonates, Foxa1 may play important roles in stage-specific functions of the lung and may influence neonatal adaptation in preterm infants who have susceptibility to respiratory distress syndrome. Foxa1 and Foxa2 are coexpressed in epithelial cells lining tubules during lung morphogenesis and in both conducting airways and alveoli in the adult lung. Both Foxa1 and Foxa2 influence the expression of a number of genes that are dynamically regulated in epithelial cells of the developing lung. The present study demonstrates that the deletion of Foxa1 perturbs maturation of the respiratory epithelium at precise times during lung morphogenesis. Foxa1 delayed the onset of sacculation and expression of differentiated epithelial cell markers before birth. Likewise, deletion of Foxa2 perturbed alveolarization in the early postnatal period.
Foxa transcription factors regulate cell differentiation in various organs such as liver, pancreas, lung, and brain. Before birth, a delay in structural maturation and expression of both proximal and peripheral epithelial cell markers of the lung was observed in the Foxa1 Ϫ/Ϫ mice. During the antenatal period, body weight as well as LW/BW ratios were similar in Foxa1 Ϫ/Ϫ mice, indicating that Foxa1 was not required for normal fetal growth, in accordance to previous findings (17) .
Foxa1
Ϫ/Ϫ mice did not gain weight after PN3 despite evidence of suckling. LW/BW ratio in Foxa1 Ϫ/Ϫ mice was similar to that in Foxa1 ϩ/ϩ mice. Previous studies showed that caloric restriction causes a delay in lung morphogenesis, with more prominent effects observed during phases of growth and differentiation (23, 30, 35) . Although surfactant phospholipid content was reduced, surfactant composition was normal in lungs of calorie-deprived animals before birth or during adulthood (8, 23) . Thus Foxa1 deletion delayed lung maturation independently of fetal growth.
Deletion of Foxa1 causes stage-specific delay in lung maturation. Before birth, Foxa1 deletion in the mouse lung delayed maturation of alveolar type II cells and bronchiolar Clara cells. Immunostaining for SP-B and SP-C was detected in the Foxa1 Ϫ/Ϫ mice but was reduced, whereas CCSP staining and mRNA were markedly delayed in the Foxa1 Ϫ/Ϫ mice before birth. A discrepancy between mRNA levels and protein expression was observed for SP-B and SP-C. These results suggested that posttranscriptional mechanisms also influence surfactant protein expression and function. Lower SP-B and SP-C protein levels may be influenced by alterations in processing, routing, storage, secretion, and reuptake and are therefore not entirely dependant on transcriptional effects of Foxa1. Despite stage-specific decreases in SP-B and SP-C, Foxa1 Ϫ/Ϫ mice survived at birth. It is possible that the delay in matura- Foxa1 deletion impairs the timing of perinatal alveolarization. In the mouse, alveolarization occurs in the postnatal period (PN4 -PN21). In Foxa1 Ϫ/Ϫ mice alveolarization was dramatically reduced at PN5 with a delay in formation of the secondary septa. However, expression of surfactant proteins and CCSP was identical in Foxa1 Ϫ/Ϫ mice compared with wild-type controls at PN5. Despite a delay in alveolar septation, respiratory function was maintained in the Foxa1 (24), and induce the expression of various markers of epithelial cell differentiation, including CCSP, SP-A, SP-B, and SP-C (31). In neonatal rats, glucocorticoids inhibit alveolarization, resulting in fewer and larger alveoli in the mature lung (25) . Although alveolarization was perturbed in Foxa1 Ϫ/Ϫ mice, alveolarization had nearly normalized by PN13, indicating Foxa1 deletion did not permanently impair septation. In contrast, glucocorticoid exposure caused prolonged abnormalities in alveolar structure in rats (25) . Whether changes in systemic glucocorticoids represent a compensatory mechanism by which lung maturation in Foxa1 Ϫ/Ϫ mice is restored remains to be clarified.
Lung structure and gene expression, although impaired at precise times in Foxa1 Ϫ/Ϫ mice, were restored at critical times in development, allowing breathing at birth and alveolarization postnatally. At E18.5, lung morphology and expression levels of SP-A, SP-B, SP-C, and SP-D, but not CCSP, were similar in Foxa1 Ϫ/Ϫ and Foxa1 ϩ/ϩ mice, indicating that an acceleration in lung maturation had occurred in the mutant mice. At PN13, alveolarization had improved markedly, indicating that acceleration of lung maturation had occurred in Foxa1 Ϫ/Ϫ mice. We hypothesize that strong compensatory pathways correct the delay in lung maturation in Foxa1 Ϫ/Ϫ mice, enabling respiratory function at birth and alveolarization during the postnatal period. Septation had improved by PN13 despite the growth retardation related to metabolic abnormalities in Foxa1 Ϫ/Ϫ mice. Thus alveolar function and structure were maintained despite caloric deprivation and high levels of serum cortisol (25, 26) .
The stage-specific recovery of maturation in lungs of the Foxa1 Ϫ/Ϫ mice provides evidence that Foxa2 and/or other transcription factors are able to compensate for the lack of Foxa1. Foxa1 and Foxa2 share a highly conserved DNA binding motif and may compete for certain targets and, hence, may have both complementary and distinct functions at specific transcriptional targets (11, 17) . Foxa1 mRNA was in- creased after deletion of Foxa2 in respiratory epithelial cells (42) . In a recent study, Wan et al. (40) showed a 1.5-fold increase in Foxa2 mRNA in a microarray analysis of E18.5 Foxa1 Ϫ/Ϫ lungs. In the present work, Foxa2 mRNA levels and staining were similar in Foxa1 ϩ/ϩ and Foxa1 Ϫ/Ϫ lungs. These results are supported by previous work of Kaestner et al. (19) , showing that expression of Foxa2 and Foxa3 was not induced by the lack of Foxa1 in the liver.
Shared and distinct functions of Foxa1 and Foxa2. Foxa1 and Foxa2 regulate transcription of a number of genes expressed in the respiratory epithelium in vitro, including Sftpb and Scgblal (5, 6, 10, 37) . In the present study, Foxa1 transactivated the mouse SP-A promoter in HeLa cells. A putative Foxa binding site was described by Alcorn et al. (1) on the SP-A promoter. In the Foxa2 ⌬/⌬ mice, SP-A mRNA was significantly reduced, suggesting that Foxa2 regulates the SP-A promoter (41) . It is surprising that Foxa1 inhibited the SP-C promoter in MLE-15 cells. These results are supported by previous findings demonstrating that Foxa1 did not activate an SP-C/CAT expression construct in MLE-15 cells (20) . In the present study and that by Wan et al. (41) , no changes were observed in SP-C expression in the Foxa1 Ϫ/Ϫ and the Foxa2 ⌬/⌬ mice. However, mice lacking both Foxa1 and Foxa2 in the respiratory epithelium completely lacked SP-C expression, demonstrating that a Foxa family member is required, either directly or indirectly, for expression of SP-C. As previously described (37), the rat CCSP promoter was activated by Foxa1 in HeLa cells in vitro. In the Foxa1 Ϫ/Ϫ mice, CCSP mRNA content and immunostaining were markedly reduced before birth, suggesting that Foxa1 plays a critical role in the perinatal regulation of CCSP. However, after birth, CCSP expression was similar in the Foxa1 Ϫ/Ϫ and Foxa1 ϩ/ϩ mice, again indicating that compensatory mechanisms restored CCSP expression. In the present study, Foxa1 activated the mouse SP-D promoter, consistent with previous studies using the human SP-D promoter (14) . Surprisingly, SP-B promoters were inhibited by cotransfection of Foxa1 cDNA in MLE-15 cells and H441 cells. Because Foxa1 plays dual roles in gene regulation by enhancing gene transcription and by acting on chromatin remodeling (9, 27) , differences in activities of Foxa1 on the SP-B promoter may be cell type specific or influenced by developmental processes (6, 10) . Because Foxa1 Ϫ/Ϫ mice survived perinatally despite decreased SP-B staining, SP-B concentrations were adequate for respiratory function. Absence or severe reduction of SP-B in the fetal or adult lung is sufficient to cause respiratory failure (28, 44) .
Deletion of Foxa1 caused specific delays in gene expression and structural maturation of the lung. Such stage-specific delay in maturation may influence perinatal adaptation in preterm and term neonates. Because Foxa1 regulates a number of genes critical for pulmonary homeostasis, abnormalities in the structure, function, or regulation of Foxa1 may render individuals susceptible to lung injury or disease after birth.
